SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-073046
Filing Date
2019-12-16
Accepted
2019-12-16 16:31:04
Documents
4
Period of Report
2019-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1925255-1_8k.htm 8-K 26810
2 EXHIBIT 10.1 tm1925255d1_ex10-1.htm EX-10.1 61437
3 EXHIBIT 10.2 tm1925255d1_ex10-2.htm EX-10.2 37493
4 EXHIBIT 10.3 tm1925255d1_ex10-3.htm EX-10.3 34974
  Complete submission text file 0001104659-19-073046.txt   161955
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 191287474
SIC: 2834 Pharmaceutical Preparations